Multiparametric Protocol for Assessment of Intraprocedural Result of MITRACLIP Procedure

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06184789

Acronym

IPCLIP-2020

Enrollment

Registered

2023-12-28

Start date

2020-04-27

Completion date

2025-12-31

Last updated

2023-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Residual Mitral Regurgitation

Keywords

MitraClip, Residual Mitral Regurgitation, Mitral Insufficiency

Brief summary

Quantification of residual mitral regurgitation (MR) after MitraClip may be challenging. Quantitative methods for severity assessment may be inaccurate and recent recommendations suggest an assessment of changes in both hemodynamic and echocardiographic parameters, but an established prospectively validated approach is still lacking.

Interventions

DIAGNOSTIC_TESTEchocardiographic assessment

Echocardiographic and hemodynamics assessment of Mitraclip results

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* Patients with either degenerative or functional, severe or moderate to severe mitral regurgitation (MR) undergoing percutaneous edge-to-edge repair at San Raffaele Hospital from April 2019.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Efficacy of multiparametric assessment of mitral regurgitation ofter Mitraclip	one month

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026